No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs563582067 |
chr9:136819718-136819719 |
Weak transcription Enhancers Strong transcription Genic enhancers Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs145618177 |
chr9:136819727-136819728 |
Weak transcription Enhancers Strong transcription Genic enhancers Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs537566614 |
chr9:136819730-136819731 |
Weak transcription Enhancers Strong transcription Genic enhancers Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs556197989 |
chr9:136819731-136819732 |
Weak transcription Enhancers Strong transcription Genic enhancers Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs145249866 |
chr9:136819752-136819753 |
Weak transcription Enhancers Strong transcription Genic enhancers Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs149164241 |
chr9:136819758-136819759 |
Weak transcription Enhancers Strong transcription Genic enhancers Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs147590370 |
chr9:136819771-136819772 |
Weak transcription Enhancers Strong transcription Genic enhancers Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs560666425 |
chr9:136819772-136819773 |
Weak transcription Enhancers Strong transcription Genic enhancers Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs56033609 |
chr9:136819786-136819787 |
Weak transcription Enhancers Strong transcription Genic enhancers Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs76996122 |
chr9:136819814-136819815 |
Enhancers Weak transcription Strong transcription Genic enhancers Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs546476705 |
chr9:136819831-136819832 |
Enhancers Weak transcription Strong transcription Genic enhancers Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs564683218 |
chr9:136819839-136819840 |
Enhancers Weak transcription Strong transcription Genic enhancers Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs530968678 |
chr9:136819878-136819879 |
Enhancers Weak transcription Strong transcription Genic enhancers Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs143572253 |
chr9:136819880-136819881 |
Enhancers Weak transcription Strong transcription Genic enhancers Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs77413158 |
chr9:136819896-136819897 |
Enhancers Weak transcription Strong transcription Genic enhancers Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs147643598 |
chr9:136819898-136819899 |
Enhancers Weak transcription Strong transcription Genic enhancers Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs10673098 |
chr9:136819899-136819900 |
Enhancers Weak transcription Strong transcription Genic enhancers Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs34734359 |
chr9:136819900-136819901 |
Enhancers Weak transcription Strong transcription Genic enhancers Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs56407127 |
chr9:136819901-136819902 |
Enhancers Weak transcription Strong transcription Genic enhancers Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs561935538 |
chr9:136819915-136819916 |
Enhancers Weak transcription Strong transcription Genic enhancers Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs7863294 |
chr9:136819921-136819922 |
Enhancers Weak transcription Strong transcription Genic enhancers Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs547672073 |
chr9:136819925-136819926 |
Enhancers Weak transcription Strong transcription Genic enhancers Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs141420217 |
chr9:136819956-136819957 |
Enhancers Weak transcription Strong transcription Genic enhancers Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs503376 |
chr9:136819962-136819963 |
Enhancers Weak transcription Strong transcription Genic enhancers Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
25 |
rs533922001 |
chr9:136819963-136819964 |
Enhancers Weak transcription Strong transcription Genic enhancers Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs552186110 |
chr9:136819996-136819997 |
Enhancers Weak transcription Strong transcription Genic enhancers Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs148028332 |
chr9:136820009-136820010 |
Enhancers Weak transcription Strong transcription Genic enhancers Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs143598029 |
chr9:136820013-136820014 |
Enhancers Weak transcription Strong transcription Genic enhancers Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs539900723 |
chr9:136820020-136820021 |
Enhancers Weak transcription Strong transcription Genic enhancers Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs537969356 |
chr9:136820066-136820067 |
Enhancers Weak transcription Strong transcription Genic enhancers Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs549025876 |
chr9:136820085-136820086 |
Enhancers Weak transcription Strong transcription Genic enhancers Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs192208946 |
chr9:136820100-136820101 |
Enhancers Weak transcription Strong transcription Genic enhancers Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs539807717 |
chr9:136820108-136820109 |
Enhancers Weak transcription Strong transcription Genic enhancers Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs146194241 |
chr9:136820125-136820126 |
Enhancers Weak transcription Strong transcription Genic enhancers Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs370497839 |
chr9:136820130-136820131 |
Enhancers Weak transcription Strong transcription Genic enhancers Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs142924247 |
chr9:136820163-136820164 |
Enhancers Weak transcription Strong transcription Genic enhancers Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs553504201 |
chr9:136820184-136820185 |
Enhancers Weak transcription Strong transcription Genic enhancers Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs118073576 |
chr9:136820216-136820217 |
Enhancers Weak transcription Genic enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs576323036 |
chr9:136820372-136820373 |
Enhancers Weak transcription Genic enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs535724335 |
chr9:136820432-136820433 |
Weak transcription Enhancers Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs373771237 |
chr9:136820434-136820435 |
Weak transcription Enhancers Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs111467193 |
chr9:136820445-136820446 |
Weak transcription Enhancers Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs182925390 |
chr9:136820460-136820461 |
Weak transcription Enhancers Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs572813436 |
chr9:136820516-136820517 |
Weak transcription Enhancers Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs369024369 |
chr9:136820524-136820525 |
Weak transcription Enhancers Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs62576939 |
chr9:136820594-136820595 |
Weak transcription Enhancers Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
47 |
rs2428005 |
chr9:136820604-136820605 |
Weak transcription Enhancers Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
48 |
rs200697948 |
chr9:136820695-136820696 |
Weak transcription Enhancers Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs187896209 |
chr9:136820784-136820785 |
Weak transcription Enhancers Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs410383 |
chr9:136820814-136820815 |
Enhancers Weak transcription Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|